Keith Robison at Omics! Omics! points out a paper in PNAS in which Regeneron shows that a compound it developed called VEGF-Trap can be used to measure the amount of circulating VEGF (vascular endothelial growth factor) in blood. VEGF is a signaling molecule that stimulates angiogenesis, and is therefore used to determine dosage for drugs used to treat cancer.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.